Nuclera
Drug Discovery · Laboratory Equipment
Startup · Series CRaised $12M · Series C · Jan 20263 backers: CIC, Future Planet Capital+1Visa sponsor: United States, United Kingdom
$87MTotal raised
3Open roles1 posted in 30 days+1 this week
$259kPublic contracts won2 public contracts
Data updated Nov 21, 2026Money ledger: 2 records from 1 sourceAnnounced 2Full reportReport a mistake
Facts
as of Nov 21, 2026Rapid protein prototyping, making proteins accessible — it’s what we do. It’s what we deliver. Click here to learn more.
It is hiring: 3 open roles, 1 of them posted in the last 30 days.
- Founded
- 2013
- Employees
- 201-500estimated range
- Open roles
- 3Alion job postings
- Official records
- Wikidata Q107519293
- Website
- nuclera.com
As of Nov 21, 2026, Alion lists 3 open roles at Nuclera. It was founded in 2013. It has raised $87M in 2 funding rounds. The latest round is Series C of $12M, announced in 2026.
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
Funding
Full ledger, 2 records →Nuclera has $87M paid in by investors, lenders and donors.
$87MPaid in
Money innewest first
$12MPaid
$75MPaid
Money by yearUSD, rounds and grants
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".
Ownership
All holders and entities →Nuclera operates through 1 legal entity in 1 country.
Named investors, no share stated1
Elevage Medical T
Legal entities1 in 1 country
subsidiary · GB CRN 08663936
GB
Holders and shares as each register or filing states them.
People
All open roles →3 open roles, 1 of them posted in the last 30 days.
3Open roles1 posted in 30 days
38People on payrollPERM filings, 2026
Where the openings areshare of open roles
Source: the company's careers site, read by Alion several times a day; market medians from all open roles of the same family
Products
2 public contracts won, $259k in all.
Biggest buyers2 · $259k
NPL Management Limited
United Kingdom · 1 public contract
$227k
Defence Science and Technology Laboratory
United Kingdom · 1 public contract
$32k
Risk
Full record →Nuclera: 6 research papers in five years.
No match
None
None
Patents
1
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Milestones
Newsroom
Newsmanchempharma
Oct 1
Sources: the outlets named on each headline, each story once
